У нас вы можете посмотреть бесплатно Hemp And Marijuana Industries Leaders Potentially Aligning? | TTB Powered by Flowhub или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
On our latest Trade To Black podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell break down several stories currently making headlines across the cannabis industry. We begin in Florida, where the state Supreme Court rejected an appeal from marijuana legalization advocates attempting to restore invalidated ballot signatures. The decision effectively ends the campaign’s effort to place adult-use cannabis legalization on the 2026 ballot, closing the door — at least for now — on what many believed could have been one of the largest potential cannabis markets in the United States. We also look at new reporting suggesting that leaders from the hemp and marijuana industries may be finding some common ground on federal policy priorities. With cannabis rescheduling still under review in Washington and Farm Bill negotiations continuing in Congress, some stakeholders believe a more unified industry position could influence how cannabinoids are regulated moving forward. In addition, we discuss new research out of the Hebrew University of Jerusalem examining how cannabinoids like CBD and CBG may impact metabolic dysfunction-associated steatotic liver disease, known as MASLD. Early findings suggest these compounds could help reduce liver fat and improve metabolic function. Finally, Omar Khan, Chief Communications Officer at High Tide Inc. (NASDAQ: HITI | TSXV: HITI), joins the show to discuss the company’s decision to become a founding member of the National Compassionate Care Council and what that initiative aims to accomplish as federal cannabis policy discussions continue. 00:00:00 Intro, market check & today’s lineup (High Tide, NCCC, Florida, liver study) 00:04:21 Who is High Tide’s Omar Khan & why NCCC matters for US medical cannabis 00:07:25 What is the NCCC? Goals, members & how it could shape US policy 00:13:03 Where the real opportunity is: medical vs adult-use (US & Europe) 00:19:39 Who will actually control US medical cannabis policy? Feds vs states vs industry 00:23:40 Florida adult-use setback: why the Florida thesis is still intact 00:28:19 Hemp vs marijuana: federal policy fight & industry alignment debate 00:32:26 New Israeli research: CBD/CBG, fatty liver disease & the future of cannabinoid medicine #CannabisNews #CannabisPolicy #HighTide, #FloridaCannabis #CBDResearch #CBG #MedicalMarijuana #CannabisIndustry #CannabisReform #TradeToBlack Want to see more Cannabis Reform videos? 🎬 • Georgia Lawmakers Push Cannabis Rescheduli... 🎬 • Would Bondi’s Removal Stop Rescheduling? |... 🎬 • Why Rescheduling Alone Won’t Fix Cannabis ... 🎬 • Massachusetts Voters Reject Cannabis Rollb... Want to stay updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked newsletter: https://newsletter.thedalesreport.com... Find us on social media and podcast platforms: ✅ Facebook: / thedalesreport ✅ Twitter: / thedalesreport ✅ Instagram: / dalesreport ✅ LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon... Spotify: https://tinyurl.com/TDRTradeToBlackon... Website: https://thedalesreport.com/ For copyright matters, contact: sdales@thedalesreport.com Podcast Disclaimer (Financial Interests) The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice. The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions. By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed. Full Disclosures: https://thedalesreport.com/website-te...